Skip to main content
Home
Blogs
Groups
Maps
Links
Resources
Resource items
Resource nodes
About
User login
Username
*
Password
*
Create new account
Request new password
lake
What is the weather on the sun
Search form
Search
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
More than half of US states reporting 'very high' COVID activity levels- CDC
COP28: The climate crisis is also a health crisis
Uganda takes the lead: piloting the Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research
Over 40 million health professionals demand bold health and climate action at COP28
Five grassroots climate justice movements COP28 could learn from
Recent Comments
WHO convening meeting to discuss Mpox status in Africa
2 weeks 2 days ago
Writing is on the wall for the US at COP29 --BBC
2 weeks 3 days ago
Update: Biden announced vaccine doses and cash for Africa
2 months 5 days ago
WHO's authorization of mpox vaccine should ease global access
2 months 1 week ago
Who's online
There are currently 0 users online.
You are here
Home
Treatments
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Fri, 2022-08-19 16:38 —
mike kraft
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday.
Reuters
Reuters
...
Country / Region Tags:
United States
General Topic Tags:
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?:
Situation Report
Read more
about FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Log in
or
register
to post comments
How to assess risk for long term Covid issues--CNN
Fri, 2022-08-19 09:56 —
mike kraft
Long Covid risk extends two years after infection. Here's how to assess your risk
A new study found an increased risk of certain long Covid-19 symptoms up to two years after an original infection.
Sandee LaMotte, CNN
CNN
Country / Region Tags:
Global
United States
General Topic Tags:
COVID-19
Symptoms
Treatments
Disease
Disease Prevention
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?:
Analysis
Read more
about How to assess risk for long term Covid issues--CNN
Log in
or
register
to post comments
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
howdy folks
Page loaded in 0.537 seconds.
Recent Comments